Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Noninterventional Study Assessing the Real-Life Use of The Long-Acting 6-Month Triptorelin Formulation as A Treatment for Different Stages of Prostate Cancer in Italy - REAL6T

NCT05759273 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT05759273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Noninterventional Study Assessing the Real-Life Use of The Long-Acting 6-Month Triptorelin Formulation as A Treatment for Different Stages of Prostate Cancer in Italy - REAL6T
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
April 24, 2023
Completion date
September 30, 2024
Enrollment
167 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer